Skip to main content

Table 2 Nutritional status measures across the diagnostic groups

From: Nutritional status and quality of life in interstitial lung disease: a prospective cohort study

 

Total

IPF

CTD-ILD

Non-IPF/non-CTD

 

(n = 90)

(n = 27)

(n = 34)

(n = 29)

Weight (kg)

77.8 (27.5)

76.7 (20.6)

75.4 (27.3)

78.5 (29.8)

BMI (kg/m2)

28.3 (7.7)

26.8 (5.6)

28.7 (8.7)

30.6 (9.7)

Underweight

4 (4.4%)

1 (3.7%)

1 (2.9%)

2 (6.9%)

Healthy weight

41 (45.6%)

20 (74.1%)

12 (35.3%)

9 (31.0%)

Overweight/obese

45 (50%)

6 (22.2%)

21 (61.8%)

18 (62.0%)

SGA

    

 A

82 (91.1%)

22 (81.5%)

34 (100.0%)

26 (89.7%)

 B

8 (8.9%)

5 (18.5%)

0 (0.0%)

3 (10.3%)

 C

0

0

0

0

Grip strength (kg)

22 (15.9)

27.0 (16.3)

19.2 (17.7)

19.7 (10.6)

% Predicted grip strength

71.0 (25.3)

74.7 (20.5)

70.0 (28.7)

70.3 (28.4)

TSFa,b (mm)

22.0 (15.1)

19.5 (7.6)

23.8 (12.9)

24.5 (16.8)

TSF percentile

75th–90th

50th–75th

50th–75th

75th–90th

 Data missing

8

0

2

6

MAC (cm)

30 (4.3)

29.6 (3.4)

31.8 (4.5)

30.8 (6.5)

MAC percentile

50th–75th

25th–50th

50th–75th

50th–75th

 Data missing

6

0

1

5

MAMC (cm)

23.7 (4.1)

24.3 (5.6)

23.7 (3.8)

23.3 (5.0)

MAMC percentile

25th–50th

25th–50th

50th–75th

10th–25th

 Data missing

8

0

2

6

EQ-5D-5L

    

 Index Value (− 0.594 to 1)

0.727 (0.232)

0.762 (0.201)

0.725 (0.210)

0.683 (0.286)

 VASb,c (0–100)

70.0 (25.0)

75.0 (20.0)

77.5 (26.0)

60.0 (33.0)

K-BILD (0–100)

    

 Total score

66.7 (17.5)

70 (32.2)

67.2 (33.3)

61.7 (32.2)

 Breathlessness and activity

45.8 (45.8)

45.8 (45.8)

50.0 (43.8)

35.4 (46.9)

 Chest symptoms

77.8 (27.8)

77.8 (27.8)

77.8 (27.8)

77.8 (48.6)

 Psychological

71.4 (39.3)

73.8 (40.5)

72.6 (32.1)

63.1 (35.1)

  1. Data shown as number (percent) or median (interquartile range)
  2. IPF idiopathic pulmonary fibrosis, CTD-ILD connective-tissue disease associated interstitial lung disease, BMI body mass index, SGA subjective global assessment, TSF triceps skinfold, MAC mid-arm circumference, MAMC mid-arm muscle circumference
  3. aSignificant difference between IPF and CTD-ILD
  4. bSignificant difference between IPF and non-IPF/non-CTD
  5. cSignificant difference between CTD-ILD and non-IPF/non-CTD